Aug 10 (Reuters) - Aurinia Pharmaceuticals Inc-
* Aurinia reports second quarter 2017 financial results, and provides operational highlights
* Aurinia Pharmaceuticals Inc qtrly loss per share $0.03
* Aurinia Pharmaceuticals - believe, based on current plans, co has financial resources to complete aurora trial and regulatory submission process Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.